Neumora Therapeutics, Inc. (NMRA)
NASDAQ: NMRA · Real-Time Price · USD
1.500
+0.060 (4.17%)
At close: Aug 12, 2025, 4:00 PM
1.480
-0.020 (-1.33%)
After-hours: Aug 12, 2025, 5:54 PM EDT
Paramount Global Market Cap
Neumora Therapeutics has a market cap or net worth of $242.92 million as of August 12, 2025. Its market cap has decreased by -87.73% in one year.
Market Cap
242.92M
Enterprise Value
45.29M
1-Year Change
-87.73%
Ranking
Category
Stock Price
$1.50
Market Cap Chart
Since the IPO on September 15, 2023, Neumora Therapeutics's market cap has decreased from $2.58B to $242.92M, a decrease of -90.60%. That is a compound annual growth rate of -71.05%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 11, 2025 | 233.20M | -86.38% |
| Dec 31, 2024 | 1.71B | -34.22% |
| Dec 29, 2023 | 2.60B | 0.79% |
| Sep 15, 2023 | 2.58B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 574.04B |
| Johnson & Johnson | 416.11B |
| AbbVie | 350.91B |
| UnitedHealth Group | 236.90B |
| AstraZeneca | 232.33B |
| Novartis AG | 230.64B |
| Abbott Laboratories | 228.03B |
| Novo Nordisk | 223.00B |